Stock Price
0.75
Daily Change
0.03 4.17%
Monthly
63.04%
Yearly
697.87%
Q2 Forecast
0.71

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025